NCT05467579

Brief Summary

There is currently no information on how mandibular advancement therapy could influence three-dimensionally the condylar and mandibular morphology in growing patients affected by Juvenile Idiopathic Arthritis (JIA). Therefore, the aim is to assess the three-dimensional morphological mandibular changes produced by the Invisalign® Mandibular Advancement (MA) (Align Technology, San José, CA, USA) in growing subjects affected by juvenile idiopathic arthritis with unilateral and bilateral JIA and to compare them with not-JIA control subjects

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 14, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 20, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

October 1, 2022

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2025

Completed
Last Updated

July 20, 2022

Status Verified

July 1, 2022

Enrollment Period

1.3 years

First QC Date

July 14, 2022

Last Update Submit

July 19, 2022

Conditions

Outcome Measures

Primary Outcomes (5)

  • Improvement of the facial profile

    Clinical evaluation in vivo (binary outcome yes/no)

    12 months

  • Mandibular growth achievement

    Measured on CBCT scans (increase in mm of the mandibular length, superimposition of the 3D reconstruction of the condyles)

    12 months

  • Presence of inflammation during active phase of mandibular advancement

    To monitoring TMJ inflammation during the active phase of treatment comparing the MRI taken before the beginning of therapy with those taken as controls every six months until the end of treatment and to evaluate patient's reported outcomes regarding treatment with mandibular advancement both in JIA and in the healthy control group

    12 months

  • Discomfort during active phase

    Discomfort reported on a questionnaire during all the active phase of treatment recorded every 6 month (VAS scale, pain min-max 0-100)

    6 months

  • Discomfort during active phase

    Discomfort reported on a questionnaire during all the active phase of treatment recorded every 6 month (VAS scale, pain min-max 0-100)

    12 months

Study Arms (2)

Healthy subjects

ACTIVE COMPARATOR

Healthy patients that will serve as controls will recruited having the same demographic characteristics of the experimental group i.e., age, sex, vertebral maturation stage and the same cranio-facial features, skeletal class II, class II division 1 malocclusion, mandibular retrognathia, normal/hyperdivergent growth pattern.

Device: Device: orthodontic - mandibular advancement clear aligner

JIA subjects

EXPERIMENTAL

Young people aged from 10 to 14 years old with skeletal class II, class II division 1 malocclusion, mandibular retrognathia, normal/hyperdivergent growth pattern, and affected by juvenile idiopathic arthritis

Device: Device: orthodontic - mandibular advancement clear aligner

Interventions

Intervention orthodontic - mandibular advancement: mandibular retrognathia correction with a mandibular advancement using a step-wise approach with clear aligner.

Also known as: MA clear aligner; activator appliances
Healthy subjectsJIA subjects

Eligibility Criteria

Age8 Years - 14 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may not qualify if:

  • Previous orthodontic or orthopedic treatment with any type of intervention (to avoid confounding factors related to previous treatment)
  • Patients with severe transverse dental or skeletal discrepancies
  • Syndromes, orofacial cleft, or other special needs, except for Juvenile idiopathic arthritis
  • Missing teeth (to avoid confounding factors related to anchorage loss due to the absence or early extraction of permanent teeth)
  • Poor oral health that precludes orthodontic treatment (presence of caries, active white spots or periodontal diseases)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Università di Milano, Ospedale maggiore Policlincio, IRCCS Cà Granda

Milan, Itali, 20100, Italy

Location

MeSH Terms

Conditions

Arthritis, JuvenileMalocclusion, Angle Class II

Interventions

Activator Appliances

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System DiseasesMalocclusionTooth DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

Orthodontic Appliances, FunctionalOrthodontic AppliancesOrthodonticsDentistryOrthodontic Appliances, Removable

Central Study Contacts

Alessandro Ugolini, DDS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

July 14, 2022

First Posted

July 20, 2022

Study Start

October 1, 2022

Primary Completion

January 1, 2024

Study Completion

January 1, 2025

Last Updated

July 20, 2022

Record last verified: 2022-07

Locations